Publicacións en colaboración con investigadores/as de University of South Florida (4)

2024

  1. Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data

    World Allergy Organization Journal , Vol. 17, Núm. 7

2023

  1. Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology

    World Allergy Organization Journal, Vol. 16, Núm. 2

2021

  1. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10

  2. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1041-1052